Ets-1 Regulates Energy Metabolism in Cancer Cells

Cancer cells predominantly utilize glycolysis for ATP production even in the presence of abundant oxygen, an environment that would normally result in energy production through oxidative phosphorylation. Although the molecular mechanism for this metabolic switch to aerobic glycolysis has not been fully elucidated, it is likely that mitochondrial damage to the electron transport chain and the resulting increased production of reactive oxygen species are significant driving forces. In this study, we have investigated the role of the transcription factor Ets-1 in the regulation of mitochondrial function and metabolism. Ets-1 was over-expressed using a stably-incorporated tetracycline-inducible expression vector in the ovarian cancer cell line 2008, which does not express detectable basal levels of Ets-1 protein. Microarray analysis of the effects of Ets-1 over-expression in these ovarian cancer cells shows that Ets-1 up-regulates key enzymes involved in glycolysis and associated feeder pathways, fatty acid metabolism, and antioxidant defense. In contrast, Ets-1 down-regulates genes involved in the citric acid cycle, electron transport chain, and mitochondrial proteins. At the functional level, we have found that Ets-1 expression is directly correlated with cellular oxygen consumption whereby increased expression causes decreased oxygen consumption. Ets-1 over-expression also caused increased sensitivity to glycolytic inhibitors, as well as growth inhibition in a glucose-depleted culture environment. Collectively our findings demonstrate that Ets-1 is involved in the regulation of cellular metabolism and response to oxidative stress in ovarian cancer cells.

[1]  K. Fujikawa,et al.  The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor , 1998, International journal of cancer.

[2]  Weiya Ma,et al.  Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins. , 2000, Carcinogenesis.

[3]  M. Akıncı,et al.  Oxidant/antioxidant balance in patients with thyroid cancer. , 2008, Acta cirurgica brasileira.

[4]  P. Andrews,et al.  Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells. , 1992, Cancer research.

[5]  O. Podhajcer,et al.  Imbalance of antioxidant enzymes in tumor cells and inhibition of proliferation and malignant features by scavenging hydrogen peroxide , 2004, Molecular carcinogenesis.

[6]  U. Ray,et al.  Antioxidant and oxidative stress responses of sojourners at high altitude in different climatic temperatures , 2010, International journal of biometeorology.

[7]  A. von Deimling,et al.  Ets‐1 is up‐regulated together with its target gene products matrix metalloproteinase‐2 and matrix metalloproteinase‐9 in atypical and anaplastic meningiomas , 2006, Histopathology.

[8]  Hirotaka Yamamoto,et al.  Role of the transcription factor Ets-1 in cisplatin resistance. , 2004, Molecular cancer therapeutics.

[9]  S. Passi,et al.  Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma. , 1996, The Journal of investigative dermatology.

[10]  S. Kiriakidis,et al.  The transcription factor ETS-1: its role in tumour development and strategies for its inhibition. , 2008, Mini reviews in medicinal chemistry.

[11]  T. Tamaya,et al.  Clinical implications of expression of ETS-1 related to angiogenesis in uterine cervical cancers. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  N. Holbrook,et al.  Cellular response to oxidative stress: Signaling for suicide and survival * , 2002, Journal of cellular physiology.

[13]  M. Abe,et al.  ETS‐1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3 , 1999, Journal of cellular physiology.

[14]  Robert Nadon,et al.  A correction for estimating error when using the Local Pooled Error Statistical Test , 2008, Bioinform..

[15]  Kai Chen,et al.  Activation of p53 by Oxidative Stress Involves Platelet-derived Growth Factor-β Receptor-mediated Ataxia Telangiectasia Mutated (ATM) Kinase Activation* , 2003, Journal of Biological Chemistry.

[16]  S. Weinhouse,et al.  Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. , 1953, Cancer research.

[17]  R. Scarpulla,et al.  Nuclear activators and coactivators in mammalian mitochondrial biogenesis. , 2002, Biochimica et biophysica acta.

[18]  J. Nesland,et al.  Ets-1 mRNA Expression in Effusions of Serous Ovarian Carcinoma Patients Is a Marker of Poor Outcome , 2001, The American journal of surgical pathology.

[19]  Ann M. Hess,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Filtering for increased power for microarray data analysis , 2008 .

[20]  O. Warburg [Origin of cancer cells]. , 1956, Oncologia.

[21]  M Schwaiger,et al.  Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  C. Sweep,et al.  Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer , 2002, Oncogene.

[23]  H. Pelicano,et al.  Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism. , 2009, Cancer research.

[24]  Gurmit Singh,et al.  ets‐1 is transcriptionally up‐regulated by H2O2 via an antioxidant response element , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  L. Oberley,et al.  Antioxidant enzyme levels in cancer. , 1997, Histology and histopathology.

[26]  M. Kaminski,et al.  The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  John A. Hall,et al.  mtDNA mutations increase tumorigenicity in prostate cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Fagin,et al.  Expression of the Ets-1 proto-oncogene in human gastric carcinoma: correlation with tumor invasion. , 1996, The American journal of pathology.

[29]  N. Takai,et al.  c-Ets1 is a promising marker in epithelial ovarian cancer. , 2002, International journal of molecular medicine.

[30]  M. Trojanowska Ets factors and regulation of the extracellular matrix , 2000, Oncogene.

[31]  G. Semenza Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[32]  G. Schatz Mitochondria: beyond oxidative phosphorylation. , 1995, Biochimica et biophysica acta.

[33]  S. Dima,et al.  Transcriptional silencing of ETS-1 efficiently suppresses angiogenesis of pancreatic cancer , 2009, Cancer Gene Therapy.

[34]  S. Weinhouse,et al.  Metabolism of neoplastic tissue. III. Diphosphopyridine nucleotide requirements for oxidations by mitochondria of neoplastic and non-neoplastic tissues. , 1953, Cancer research.

[35]  P. Jansen-Dürr,et al.  High-resolution respirometry–a modern tool in aging research , 2006, Experimental Gerontology.

[36]  Peng Huang,et al.  Mitochondrial defects in cancer , 2002, Molecular Cancer.

[37]  K. Hallikeri,et al.  Oxidant-antioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients. , 2010, Oral diseases.

[38]  C. Nathan,et al.  Production of large amounts of hydrogen peroxide by human tumor cells. , 1991, Cancer research.

[39]  J. Nesland,et al.  Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  J. Klaunig,et al.  The role of oxidative stress in carcinogenesis. , 2004, Annual review of pharmacology and toxicology.

[41]  J. Ahn,et al.  Ets-1 upregulates HER2-induced MMP-1 expression in breast cancer cells. , 2008, Biochemical and biophysical research communications.

[42]  Jürgen Dittmer,et al.  The Biology of the Ets1 Proto-Oncogene , 2003, Molecular Cancer.

[43]  S. Erzurum,et al.  Differential expression of manganese superoxide dismutase and catalase in lung cancer. , 2001, Cancer research.

[44]  A. Bosserhoff,et al.  The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma , 2003, Cellular and Molecular Life Sciences CMLS.

[45]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[46]  G. Khomutov,et al.  Superoxide generation by the respiratory chain of tumor mitochondria. , 1987, Biochimica et biophysica acta.

[47]  N. Matevska,et al.  Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer. , 2009, Clinical biochemistry.

[48]  B. Manning,et al.  Chewing the Fat on Tumor Cell Metabolism , 2010, Cell.

[49]  Yau-Huei Wei,et al.  Mitochondrial DNA Instability and Metabolic Shift in Human Cancers , 2009, International journal of molecular sciences.

[50]  Oberley Td,et al.  Antioxidant enzyme levels in cancer. , 1997 .